Literature DB >> 12729993

In vitro susceptibility testing of filamentous fungi: comparison of Etest and reference M38-A microdilution methods for determining posaconazole MICs.

M A Pfaller1, S A Messer, L Boyken, R J Hollis, D J Diekema.   

Abstract

The performance of the Etest for posaconazole susceptibility testing of 72 isolates of filamentous fungi was assessed in comparison with the National Committee for Clinical Laboratory Standards (NCCLS) approved standard broth microdilution method (M38-A). The NCCLS method employed RPMI 1640 broth medium, and MICs were read after incubation for 48h at 35 degrees C. Etest MICs were determined with RPMI agar containing 2% glucose and were read after incubation for 48h at 35 degrees C. The isolates included Aspergillus fumigatus, A. flavus, A. nidulans, A. niger, A. versicolor, A. oryzae, A. terreus, Cladosporium spp., Curvularia sp., Exophiala sp., Fusarium spp., Paecilomyces spp., Pithomyces sp., Penicillium spp. and Scedosporium apiospermum. Overall agreement between Etest and microdilution MICs was 84% for Aspergillus spp. and 100% for the less common opportunistic molds, with the exception of Penicillium spp. (67%). Where a discrepancy was observed between Etest and the reference method, the Etest tended to give lower values. The Etest method using RPMI agar appears to be a useful method for determining posaconazole susceptibilities of filamentous fungi.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12729993     DOI: 10.1016/s0732-8893(02)00544-8

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  16 in total

1.  Evaluation of disk diffusion method for determining posaconazole susceptibility of filamentous fungi: comparison with CLSI broth microdilution method.

Authors:  E López-Oviedo; A I Aller; C Martín; C Castro; M Ramirez; J M Pemán; E Cantón; C Almeida; E Martín-Mazuelos
Journal:  Antimicrob Agents Chemother       Date:  2006-03       Impact factor: 5.191

Review 2.  Combination treatment of invasive fungal infections.

Authors:  Pranab K Mukherjee; Daniel J Sheehan; Christopher A Hitchcock; Mahmoud A Ghannoum
Journal:  Clin Microbiol Rev       Date:  2005-01       Impact factor: 26.132

3.  Comparing Etest and Broth Microdilution for Antifungal Susceptibility Testing of the Most-Relevant Pathogenic Molds.

Authors:  Frédéric Lamoth; Barbara D Alexander
Journal:  J Clin Microbiol       Date:  2015-07-22       Impact factor: 5.948

4.  Assessment of efficacy of antifungals against Aspergillus fumigatus: value of real-time bioluminescence imaging.

Authors:  Célimène Galiger; Matthias Brock; Grégory Jouvion; Amélie Savers; Marianna Parlato; Oumaïma Ibrahim-Granet
Journal:  Antimicrob Agents Chemother       Date:  2013-04-15       Impact factor: 5.191

5.  Isolation of Aspergillus caninus (Synonym: Phialosimplex caninus) from a Canine Iliac Lymph node.

Authors:  Rui Kano; Mai Sakai; Masato Hiyama; Kenji Tani
Journal:  Mycopathologia       Date:  2019-01-31       Impact factor: 2.574

6.  Comparison of assessment of oxygen consumption, Etest, and CLSI M38-A2 broth microdilution methods for evaluation of the susceptibility of Aspergillus fumigatus to posaconazole.

Authors:  Ricardo Araujo; Ana Espinel-Ingroff
Journal:  Antimicrob Agents Chemother       Date:  2009-08-24       Impact factor: 5.191

7.  Granulomatous polyarthritis caused by Talaromyces georgiensis in a dog.

Authors:  Kazuki Okada; Rui Kano; Takehiro Hasegawa; Yumiko Kagawa
Journal:  J Vet Diagn Invest       Date:  2020-10-01       Impact factor: 1.279

Review 8.  Recent advances in the management of mucormycosis: from bench to bedside.

Authors:  Brad Spellberg; Thomas J Walsh; Dimitrios P Kontoyiannis; John Edwards; Ashraf S Ibrahim
Journal:  Clin Infect Dis       Date:  2009-06-15       Impact factor: 9.079

9.  Nonsporulating clinical isolate identified as Petromyces alliaceus (anamorph Aspergillus alliaceus) by morphological and sequence-based methods.

Authors:  S Arunmozhi Balajee; Mark D Lindsley; Naureen Iqbal; James Ito; Peter G Pappas; Mary E Brandt
Journal:  J Clin Microbiol       Date:  2007-05-30       Impact factor: 5.948

10.  In vitro activities of 35 double combinations of antifungal agents against Scedosporium apiospermum and Scedosporium prolificans.

Authors:  Manuel Cuenca-Estrella; Ana Alastruey-Izquierdo; Laura Alcazar-Fuoli; Leticia Bernal-Martinez; Alicia Gomez-Lopez; Maria J Buitrago; Emilia Mellado; Juan L Rodriguez-Tudela
Journal:  Antimicrob Agents Chemother       Date:  2008-01-14       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.